Core Laboratories closed at $9.65 on Nov 4, down 1.23%, within 2.7% of its 52-week closing low. Volume of 635.7K shares was 0.93× its 20-day average (close to normal).
Split-adjusted performance: -6.3% over one month, -29.4% over six months, -40.2% over one year.
In the quarter ended Sep 30, 2026, revenue was $132.08M, down 1.8% from a year earlier, with a net margin of 4.1%.
Short interest was 4.9M shares at the Oct 15 settlement, up 1.0% from the prior report (10.9% of float, 7.3 days to cover).